Related Experiment Video
Updated: Jun 17, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Fusion prediction model for post-ERCP pancreatitis under NSAIDs prophylaxis
Wenjun Ping1, Peng Cao1, Jiangtao Li1
1The First Affiliated Hospital, Department of Hepatopancreatobiliary Surgery, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
Machine learning models can predict post-ERCP pancreatitis (PEP) in patients taking NSAIDs. A novel fusion model shows high accuracy, aiding clinical decisions for this common ERCP complication.
Area of Science:
- Gastroenterology and Hepatology
- Medical Informatics
- Artificial Intelligence in Medicine
Background:
- Endoscopic retrograde cholangiopancreatography (ERCP) is a frequent procedure for biliary and pancreatic conditions.
- Post-ERCP pancreatitis (PEP) is a significant complication, occurring in 3.5–9.7% of cases.
Purpose of the Study:
- To develop machine learning models predicting PEP risk in patients receiving prophylactic non-steroidal anti-inflammatory drugs (NSAIDs).
Main Methods:
- Retrospective analysis of 991 patients undergoing ERCP (Jan 2018–Feb 2024).
- Utilized logistic regression, LightGBM, MLP, Random Forest, and XGBoost models.
- Employed mixed sampling for data imbalance and model fusion for enhanced accuracy.
- Validated models on a prospective cohort of 124 patients.
Main Results:
- PEP developed in 5.75% (57/991) of patients.
- Identified key pre- and post-procedure risk factors for PEP.
- The fusion model achieved AUCs of 0.84 (pre-procedure) and 0.86 (post-procedure).
- Demonstrated high specificity and negative predictive values.
Conclusions:
- A novel fusion model effectively predicts PEP in NSAID-treated patients undergoing ERCP.
- The model offers improved risk stratification and clinical decision support.
- Further multi-center validation and inclusion of additional factors are recommended.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Endoscopic Procedures V: ERCP
Patient...
Acute Pancreatitis I: Introduction
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis II: Collaborative Care
Assessment:
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
